Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ignacio Blanco-Guillermo"'
Autor:
Teresa, Pàmpols Ros, Antonio, Pérez Aytés, José Miguel, García Sagredo, Aránzazu, Díaz de Bustamante, Ignacio, Blanco Guillermo
Publikováno v:
Revista espanola de salud publica. 96
Genome sequencing is a very attractive technology as it is also the idea of sequencing children at birth, with the aim to establish medical care and preventive actions during their whole life, tailored to the genome of each newborn. Part I of this ar
Autor:
Teresa, Pàmpols Ros, Antonio, Pérez Aytés, José Miguel, García Sagredo, Aránzazu, Díaz de Bustamante, Ignacio, Blanco Guillermo
Publikováno v:
Revista espanola de salud publica. 96
In 2003 at the ending of the Human Genome Project, it aroused the idea that all newborns could be sequenced and its genome archived in the clinical record, in order to manage risks of diseases and response to medicaments along his whole life. Eightee
Autor:
Carmen Yagüe-Muñoz, Ignacio Blanco-Guillermo, Esther Cabrera-Torres, Gemma Llort-Pursals, Anna Schiaffino-Rubinat
Publikováno v:
Enfermería Clínica. 16:112-118
Resumen Objetivos Conocer el grado de conocimientos sobre el cancer, la percepcion de riesgo y el estado emocional de las personas con historia familiar de cancer de mama y cancer colorrectal que acuden a una unidad de consejo genetico (UCG). Metodo
Autor:
Gemma, Llort, Carmen Yagüe, Muñoz, Mercè Peris, Tuser, Ignacio Blanco, Guillermo, José Ramón Germà, Lluch, Allen E, Bale, Mayra Alvarez, Franco
Publikováno v:
Human Mutation. 19:307-307
BRCA1 and BRCA2 mutations underlie a substantial proportion of all hereditary breast cancer. The mutational spectrum in these genes is very broad, with hundreds of different BRCA mutations reported worldwide. However, high frequency founder mutations
Autor:
Ignacio Blanco Guillermo, Carmen Muñoz, Gemma Llort, Mayra Alvarez Franco, Allen E. Bale, José Ramón Germà Lluch, Mercè Peris Tuser
Publikováno v:
Human Mutation. 19:307-307
BRCA1 and BRCA2 mutations underlie a substantial proportion of all hereditary breast cancer. The mutational spectrum in these genes is very broad, with hundreds of different BRCA mutations reported worldwide. However, high frequency founder mutations